• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

利用真实世界数据进行医疗保健的机遇与挑战。

Opportunities and challenges in using real-world data for health care.

作者信息

Rudrapatna Vivek A, Butte Atul J

机构信息

Bakar Computational Health Sciences Institute.

Division of Gastroenterology, Department of Medicine, and.

出版信息

J Clin Invest. 2020 Feb 3;130(2):565-574. doi: 10.1172/JCI129197.

DOI:10.1172/JCI129197
PMID:32011317
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6994109/
Abstract

Real-world data (RWD) continue to emerge as a new source of clinical evidence. Although the best-known use case of RWD has been in drug regulation, RWD are being generated and used by many other parties, including biopharmaceutical companies, payors, clinical researchers, providers, and patients. In this Review, we describe 21 potential uses for RWD across the spectrum of health care. We also discuss important challenges and limitations relevant to the translation of these data into evidence.

摘要

真实世界数据(RWD)正不断成为临床证据的新来源。尽管RWD最为人熟知的应用案例是在药物监管方面,但包括生物制药公司、支付方、临床研究人员、医疗服务提供者和患者在内的许多其他方也在生成和使用RWD。在本综述中,我们描述了RWD在整个医疗保健领域的21种潜在用途。我们还讨论了将这些数据转化为证据所涉及的重要挑战和局限性。

相似文献

1
Opportunities and challenges in using real-world data for health care.利用真实世界数据进行医疗保健的机遇与挑战。
J Clin Invest. 2020 Feb 3;130(2):565-574. doi: 10.1172/JCI129197.
2
Clinical Pharmacology Applications of Real-World Data and Real-World Evidence in Drug Development and Approval-An Industry Perspective.真实世界数据和真实世界证据在药物研发与审批中的临床药理学应用——行业视角
Clin Pharmacol Ther. 2023 Oct;114(4):751-767. doi: 10.1002/cpt.2988. Epub 2023 Jul 29.
3
Best practices in the real-world data life cycle.真实世界数据生命周期中的最佳实践。
PLOS Digit Health. 2022 Jan 18;1(1):e0000003. doi: 10.1371/journal.pdig.0000003. eCollection 2022 Jan.
4
Use of Real-World Evidence to Drive Drug Development Strategy and Inform Clinical Trial Design.利用真实世界证据推动药物研发策略并为临床试验设计提供信息。
Clin Pharmacol Ther. 2022 Jan;111(1):77-89. doi: 10.1002/cpt.2480. Epub 2021 Nov 28.
5
The Real-World Data Challenges Radar: A Review on the Challenges and Risks regarding the Use of Real-World Data.真实世界数据挑战雷达:关于真实世界数据使用的挑战与风险综述
Digit Biomark. 2021 Jun 24;5(2):148-157. doi: 10.1159/000516178. eCollection 2021 May-Aug.
6
RWD-Cockpit: Application for Quality Assessment of Real-world Data.真实世界数据驾驶舱:真实世界数据质量评估应用程序。
JMIR Form Res. 2022 Oct 18;6(10):e29920. doi: 10.2196/29920.
7
Leveraging Real-World Data in Safety Signal Assessment.利用真实世界数据进行安全性信号评估。
Ther Innov Regul Sci. 2024 Nov;58(6):1062-1070. doi: 10.1007/s43441-024-00682-x. Epub 2024 Aug 6.
8
Real-World Evidence: A Primer.真实世界证据:入门指南。
J Orthop Trauma. 2021 Mar 1;35(Suppl 1):S1-S5. doi: 10.1097/BOT.0000000000002037.
9
Advancing the development of real-world data for healthcare research in China: challenges and opportunities.推进中国医疗保健研究中真实世界数据的发展:挑战与机遇。
BMJ Open. 2022 Jul 29;12(7):e063139. doi: 10.1136/bmjopen-2022-063139.
10
Transferability of real-world data across borders for regulatory and health technology assessment decision-making.用于监管和卫生技术评估决策的真实世界数据跨境可转移性。
Front Med (Lausanne). 2022 Nov 16;9:1073678. doi: 10.3389/fmed.2022.1073678. eCollection 2022.

引用本文的文献

1
Decoding Immunodeficiencies with Artificial Intelligence: A New Era of Precision Medicine.利用人工智能解码免疫缺陷:精准医学的新时代。
Biomedicines. 2025 Jul 28;13(8):1836. doi: 10.3390/biomedicines13081836.
2
Methods and Observations from Routinely Collected Electronic Health Record Data in a Nationwide Jail Population: Introducing the Registry of Electronic Archives in Correctional Healthcare (REACH) Database.来自全国监狱人群中常规收集的电子健康记录数据的方法与观察:介绍惩教医疗电子档案登记处(REACH)数据库。
Health Justice. 2025 Jun 16;13(1):39. doi: 10.1186/s40352-025-00345-5.
3
[What can registries contribute to health services research?].登记处对卫生服务研究能有哪些贡献?
Pravent Gesundh. 2022 Aug 22:1-6. doi: 10.1007/s11553-022-00969-7.
4
Leveraging Synthetic Data to Facilitate Research: A Collaborative Model for Analyzing Sensitive National Cancer Registry Data in England.利用合成数据促进研究:英格兰敏感国家癌症登记数据的协作分析模型。
Ther Innov Regul Sci. 2025 Jun 5. doi: 10.1007/s43441-025-00820-z.
5
Real-World Evidence for Baricitinib in the Treatment of Atopic Dermatitis and Alopecia Areata: Systematic Literature Review 2020-2023.巴瑞替尼治疗特应性皮炎和斑秃的真实世界证据:2020 - 2023年系统文献综述
Dermatol Ther (Heidelb). 2025 May 16. doi: 10.1007/s13555-025-01425-y.
6
Continuous Improvement of Digital Health Applications Linked to Real-World Performance Monitoring: Safe Moving Targets?与真实世界性能监测相关的数字健康应用的持续改进:安全的移动目标?
Mayo Clin Proc Digit Health. 2023 Jun 25;1(3):276-287. doi: 10.1016/j.mcpdig.2023.05.010. eCollection 2023 Sep.
7
The relevance of the real-world evidence in research, clinical, and regulatory decision making.真实世界证据在研究、临床及监管决策中的相关性。
Front Public Health. 2025 Feb 18;13:1512429. doi: 10.3389/fpubh.2025.1512429. eCollection 2025.
8
Digital health technologies and innovation patterns in diabetes ecosystems.糖尿病生态系统中的数字健康技术与创新模式。
Digit Health. 2025 Feb 5;11:20552076241311740. doi: 10.1177/20552076241311740. eCollection 2025 Jan-Dec.
9
Peripheral Nerve Stimulation for Chronic Neuropathic Pain: A Health Technology Assessment.慢性神经性疼痛的外周神经刺激:一项卫生技术评估
Ont Health Technol Assess Ser. 2024 Dec 3;24(10):1-131. eCollection 2024.
10
Operationalising routinely collected patient data in research to further the pursuit of social justice and health equity: a team-based scoping review.将常规收集的患者数据用于研究以促进社会正义和健康公平的实施:一项基于团队的范围综述。
BMC Med Res Methodol. 2025 Jan 21;25(1):14. doi: 10.1186/s12874-025-02466-9.

本文引用的文献

1
Safety of Flexible Sigmoidoscopy in Pregnant Patients with Known or Suspected Inflammatory Bowel Disease.妊娠期已知或疑似炎症性肠病患者行软性乙状结肠镜检查的安全性。
Dig Dis Sci. 2020 Oct;65(10):2979-2985. doi: 10.1007/s10620-020-06122-8. Epub 2020 Feb 7.
2
Biosimilars for the Treatment of Inflammatory Bowel Disease.用于治疗炎症性肠病的生物类似药。
Pract Gastroenterol. 2019 Apr;43(4):84-91.
3
The Promise of Precision Population Health: Reducing Health Disparities Through a Community Partnership Framework.精准人群健康的前景:通过社区伙伴关系框架减少健康差距
Adv Pediatr. 2019 Aug;66:1-13. doi: 10.1016/j.yapd.2019.03.002. Epub 2019 Apr 26.
4
Early Detection of Adverse Drug Reactions in Social Health Networks: A Natural Language Processing Pipeline for Signal Detection.社会健康网络中药物不良反应的早期检测:一种用于信号检测的自然语言处理流程
JMIR Public Health Surveill. 2019 Jun 3;5(2):e11264. doi: 10.2196/11264.
5
Real-world 2-year outcome of atrial fibrillation treatment with dabigatran, apixaban, and rivaroxaban in patients with and without chronic kidney disease.伴有和不伴有慢性肾脏病的患者使用达比加群、阿哌沙班和利伐沙班治疗心房颤动的真实世界 2 年结局。
Intern Emerg Med. 2019 Nov;14(8):1259-1270. doi: 10.1007/s11739-019-02100-9. Epub 2019 May 9.
6
Children of a lesser god: exclusion of chronic kidney disease patients from clinical trials.二等公民:慢性肾病患者被临床试验排除在外。
Nephrol Dial Transplant. 2019 Jul 1;34(7):1112-1114. doi: 10.1093/ndt/gfz023.
7
Integrating Genomics into Healthcare: A Global Responsibility.将基因组学融入医疗保健:全球的责任。
Am J Hum Genet. 2019 Jan 3;104(1):13-20. doi: 10.1016/j.ajhg.2018.11.014.
8
Effectiveness and Safety of Reference Infliximab and Biosimilar in Crohn Disease: A French Equivalence Study.英夫利昔单抗与生物类似药在克罗恩病中的疗效和安全性:一项法国等效性研究。
Ann Intern Med. 2019 Jan 15;170(2):99-107. doi: 10.7326/M18-1512. Epub 2018 Dec 11.
9
Accrual to Clinical Trials (ACT): A Clinical and Translational Science Award Consortium Network.临床试验入组(ACT):临床与转化科学奖联盟网络
JAMIA Open. 2018 Oct;1(2):147-152. doi: 10.1093/jamiaopen/ooy033. Epub 2018 Aug 21.
10
Smoking Status at Diagnosis and Subsequent Smoking Cessation: Associations With Corticosteroid Use and Intestinal Resection in Crohn's Disease.诊断时的吸烟状况和随后的戒烟:与克罗恩病中皮质类固醇使用和肠道切除的关联。
Am J Gastroenterol. 2018 Nov;113(11):1689-1700. doi: 10.1038/s41395-018-0273-7. Epub 2018 Oct 15.